Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
Recruiting · NCT07702032 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1) | Left-sided Colorectal Cancer | Recruiting | Phase 3 | 2026-10-06 | NCT07702032 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genmab | 54 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Central Georgia Cancer Care - Warner Robins Office | Warner Robins | United States | 1 |
| Genesis Cancer Center | Hot Springs | United States | 5 |
| Hematology-Oncology of Indiana, P.C. | Indianapolis | United States | 1 |
| Low Country Cancer Care Associates_Savannah_1 | Savannah | United States | 1 |
| Oncology Hematology Associates - Springfield_Springfield_2 | Springfield | United States | 1 |
| PanOncology | Manati | Puerto Rico | 1 |
| Valkyrie Clinical Trials - Los Angeles | Los Angeles | United States | 2 |
| Vista Oncology | Olympia | United States | 2 |